Clinical Trial Update: REMission INDuction in Very Early Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating REMission INDuction in very early rheumatoid arthritis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: UMC Utrecht | Conditions: Arthritis, Rheumatoid | Phase 4 | Status: TERMINATED